BioAge Analysis
 The BioAge® Analysis is a novel test developed at the DaSilva Institute , which predicts aging by utilizing over 200 Biochemical Markers of Health and Disease long before symptoms or signs develop. The BioAge® Analysis is an extensive health assessment that will allow you to compare your chronological age with your biological age. Researchers at Harvard Medical School agree that “aging” itself is a disease and that its course can be slowed or even reversed. The BioAge® Analysis, therefore, emerges as a very important tool to combat the deleterious effects of the aging process. The BioAge® Analysis is the most comprehensive biochemical view of your body’s systems that will enable you to uncover functional challenges and fundamentals of life. The test affords a rare opportunity to detect danger zones years before they manifest into signs, symptoms and even disease. The BioAge® Analysis looks at over 200 biochemical markers of health and disease, which covers a span of up to 14 different medical specialties (including Cardiology, Gastroenterology, Rheumatology, Immunology, Oncology and more).This remarkable test will allow you to take a proactive approach in reducing your biological age leading to improved longevity and “health-span.” In addition, it can be performed anywhere in the United States through our national laboratory partner. The test was developed by Guy DaSilva, MD, the Medical Director at the DaSilva Institute. In the early 1990′s Dr. DaSilva was involved in the biotech industry, discovering markers for the early detection of cancer and other life threatening diseases.Dr. DaSilva’s broad background in Biochemistry, Pathology, Internal Medicine, Hematology, Bone Marrow Stem Cell technology and Molecular Medicine led to the development of the BioAge® Analysis, which he considers his most remarkable achievement to date. |
For More Information Contact Us
To schedule an appointment at the DaSilva Institute, contact a Patient Services Representative at (888) 832-7458 or click Become a New Patient.
.
 |
|
